Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · IEX Real-Time Price · USD

35.96

+0.63 (1.78%)

At close: Apr 26, 2024, 4:00 PM

36.05

+0.09 (0.25%)

After-hours: Apr 26, 2024, 5:49 PM EDT

Revolution Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	5,922	3,142	2,115	1,855	2,628
Market Cap Growth	-	48.57%	14.03%	-29.43%	-
Enterprise Value	4,154	1,374	1,533	1,343	2,219
PE Ratio	-7.20	-7.20	-8.50	-9.91	-23.81
PS Ratio	511.42	271.36	59.78	63.11	61.14
PB Ratio	3.24	1.72	3.09	3.08	5.54
P/FCF Ratio	-8.77	-8.77	-8.99	-12.07	-25.52
P/OCF Ratio	-8.96	-8.96	-9.43	-12.60	-26.26
EV/Sales Ratio	358.74	118.68	43.32	45.68	51.62
EV/EBITDA Ratio	-3.19	-3.19	-6.40	-7.47	-21.77
EV/EBIT Ratio	-3.13	-3.13	-6.15	-7.18	-20.46
EV/FCF Ratio	-3.84	-3.84	-6.52	-8.73	-21.54
Debt / Equity Ratio	0.05	0.05	0.09	0.11	0.07
Debt / EBITDA Ratio	-0.20	-0.20	-0.27	-0.37	-0.32
Debt / FCF Ratio	-0.25	-0.25	-0.27	-0.43	-0.32
Quick Ratio	12.91	12.91	10.51	9.69	9.50
Current Ratio	13.06	13.06	10.65	9.77	9.63
Asset Turnover	0.01	0.01	0.05	0.04	0.08
Interest Coverage	-1450.79	-1450.79	-	-15589.92	-1527.59
Return on Equity (ROE)	-38.40%	-38.40%	-41.20%	-28.30%	-25.60%
Return on Assets (ROA)	-33.60%	-33.60%	-33.70%	-24.50%	-21.30%
Return on Capital (ROIC)	-25.45%	-25.45%	-34.47%	-28.09%	-21.82%
Earnings Yield	-7.37%	-13.89%	-11.76%	-10.09%	-4.20%
FCF Yield	-6.05%	-11.40%	-11.12%	-8.29%	-3.92%
Buyback Yield / Dilution	-40.34%	-40.34%	-10.74%	-32.68%	-1879.17%
Total Shareholder Return	-40.34%	-40.34%	-10.74%	-32.68%	-1879.17%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).